Intravenous fosaprepitant for the prevention of chemotherapy-induced vomiting in children: A double-blind, placebo-controlled, phase III randomized trial-Reference-Cited by-同舟云学术

Intravenous fosaprepitant for the prevention of chemotherapy-induced vomiting in children: A double-blind, placebo-controlled, phase III randomized trial

Published:2018-11-13 Issue:3 Volume:66 Page:e27551
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Radhakrishnan Venkatraman¹^ORCID,Joshi Archit¹,Ramamoorthy Jaikumar¹^ORCID,Rajaraman Swaminathan²,Ganesan Prasanth¹,Ganesan Trivadi S.¹,Dhanushkodi Manikandan¹,Sagar Tenali G.¹

Affiliation:

1. Department of Medical Oncology (Pediatric Oncology Division); Cancer Institute (WIA); Chennai India

2. Department of Biostatistics; Cancer Institute (WIA); Chennai India

Funder

Cancer Institute

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.27551/fullpdf

Reference24 articles.

1. Management of chemotherapy-induced nausea and vomiting in pediatric patients;Navari;Paediatr Drugs,2017

2. Antiemetics: American Society of Clinical Oncology clinical practice guideline update;Hesketh;J Clin Oncol,2017

3. NCCN NCCN clinical practice guidelines in oncology (NCCN Guidelines®), antiemesis 2018 http://www.nccn.org/professionals/physician_gls/pdf/antiemesis.pdf

4. Guideline for the prevention of acute chemotherapy-induced nausea and vomiting in pediatric cancer patients: a focused update;Patel;Pediatr Blood Cancer,2017

5. Stability of an extemporaneous oral liquid aprepitant formulation;Dupuis;Support Care Cancer,2009

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-Emetics in Children Receiving Chemotherapy for Solid Tumors and Leukemia: Pharmacology and Optimization of Therapy for Nausea and Vomiting;Pharmaceuticals;2024-05-10

2. 2020 ASCO, 2023 NCCN, 2023 MASCC/ESMO, and 2019 CCO: a comparison of antiemetic guidelines for the treatment of chemotherapy-induced nausea and vomiting in cancer patients;Supportive Care in Cancer;2024-04-10

3. Comparison of oral aprepitant and intravenous fosaprepitant for prevention of chemotherapy-induced nausea and vomiting in pediatric oncology patients: a randomized phase III trial;Translational Pediatrics;2024-01

4. Quality of life of children with acute lymphoblastic leukemia;Paediatrica Indonesiana;2023-11-13

5. Prolonged usage of fosaprepitant for prevention of delayed chemotherapy-induced nausea and vomiting(CINV) in patients receiving highly emetogenic chemotherapy;BMC Cancer;2023-07-01